FBL and type 2 diabetes mellitus: At 20 μg mL−1 native inhibitor (N-Fib+N-Fib-IgG) concentration, the maximum % inhibition for the T2DM group was found to be 24.50 ± 5.77% (17.76-36.40); for the ATH group, it was 20.88 ± 4.58 (14.52-30.12); and for T2DM-ATH, it was 25.34 ± 5.36 (18.26-37.10).